about
Enhancing the RNA engineering toolkit.Programmable RNA Binding Proteins for Imaging and Therapeutics.CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions.CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy.Single-Cell Genomic Analysis in Plants.Selective Recognition of RNA Substrates by ADAR Deaminase Domains.Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6.RNA-targeting CRISPR comes of age.RNA Editing: Unexplored Opportunities in the Cardiovascular System.Assessing sufficiency and necessity of enhancer activities for gene expression and the mechanisms of transcription activation.CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9.New tools for old drugs: Functional genetic screens to optimize current chemotherapy.Epitranscriptomics: A New Regulatory Mechanism of Brain Development and Function.Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.Noncoding RNA:RNA Regulatory Networks in Cancer.Genomics-Enabled Next-Generation Breeding Approaches for Developing System-Specific Drought Tolerant Hybrids in Maize.Characterization and visualization of RNA secondary structure Boltzmann ensemble via information theory.Expanding RNA binding specificity and affinity of engineered PUF domains.Off and back-on again: a tumor suppressor's tale.Commentary: RNA editing with CRISPR-Cas13.Design principles for nuclease-deficient CRISPR-based transcriptional regulators.CRISPR base editors: genome editing without double-stranded breaks.Somatic mutations in neurons during aging and neurodegeneration.Optimizing CRISPR/Cas9 for the Diatom Phaeodactylum tricornutum.The Current State of Cephalopod Science and Perspectives on the Most Critical Challenges Ahead From Three Early-Career Researchers.Shooting the messenger: RNA-targetting CRISPR-Cas systems.Functional Interplay between Small Non-Coding RNAs and RNA Modification in the Brain.Unraveling of Central Nervous System Disease Mechanisms Using CRISPR Genome Manipulation.The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinomaGenetic Renal Diseases: The Emerging Role of Zebrafish ModelsRNA Therapeutics in Cardiovascular Precision MedicineCircular RNAs as Therapeutic Agents and TargetsCRISPR-Cas9/Cas12a biotechnology and application in bacteriaBlossom of CRISPR technologies and applications in disease treatmentCRISPR-Cas immunity, DNA repair and genome stabilityClass 2 CRISPR/Cas: an expanding biotechnology toolbox for and beyond genome editingSynthetic RNA-based logic computation in mammalian cells
P2860
Q47319493-CBA89A62-4EFF-4046-9097-AA2E1753D02EQ47392351-B10EBDBB-CA5F-4CF7-97D2-AFBA03B03EA8Q47547574-4DDEB59C-A2D2-4393-A67F-0DAC53EED202Q47553089-94902101-1A87-4E21-8E7E-EA9701B2CFCDQ47557398-DCF7E9D2-527F-4CDA-80D7-57473A79BAE8Q49851695-58C6D91D-994B-4DEE-96AF-91457DDA545AQ49886472-2B972C41-FE36-42DD-89E1-3A1556E68A2BQ49959418-7066B801-C5C9-46DB-9703-A363161BEF16Q50105708-8C1C8096-6B08-4A46-AF98-6EA76BE7814BQ50115938-3575461E-8FE1-448B-A84A-1F6DABEC0BA2Q52430543-3B34D755-2C52-468B-9C41-3A8B6F48C954Q52430557-48D22FB7-8DD0-45E6-85CC-61781045832CQ52430564-A44669A7-65DA-41C5-A466-8D76CF7BD3EBQ52430656-AAC49A51-D543-4FE1-A278-6CE549B0C634Q52430861-A361DF15-1913-4A02-A1A9-85BA0B4623D8Q52430863-D1025559-4B48-442D-91CB-0DBE5887F512Q52558382-26346A02-1220-4362-8536-8A88AE1AD141Q52562638-B2E66285-50BD-4B8A-912A-5E5191C5E514Q52673594-616BA27D-CA4D-43C1-AF3D-C61300102511Q52681299-030CB3EE-EC30-4A50-9C8B-878EFAF8127CQ52726519-6EC545B2-73B3-4DC2-9309-3CE32E297DC1Q55011123-950E3640-03B9-4BE5-9A52-FF1C26044307Q55097609-5F098D80-2A62-423D-AF17-DCC648E4F0A1Q55172646-DB718BA4-463F-4916-BABB-423F12939B78Q55259931-5A3FBF9C-FAF4-4BF0-85D6-2322399FC9B5Q55346877-E2CD5DD5-7099-4549-A303-A291D47D5D4EQ55380728-8E2C26BF-A0E8-4E09-9BBC-D4BDD6097A5DQ55436015-42D8AF76-6D44-4B36-9E34-C6BF8070676CQ55668403-1562B94A-4B14-4C03-ADCD-30E18AFB48FFQ55711095-CBE24A5B-3F25-47E0-9347-4134A257E6F5Q56952019-1E3A59FF-E5EC-4A50-A70C-285FE9D98BB0Q56992139-1B1E5988-C7E5-4C72-85CC-1C16F147BEA9Q57174720-695FF2EB-2CD6-4E73-8EC4-52FCAEC87B05Q57817032-3E895378-23AD-4BB9-8B76-BBD8DD79AE62Q57818221-33A32C9B-458C-4821-B879-1F46DAF9C77FQ58120494-496D0563-02AC-4FFE-A551-63A4CB97C062Q58708003-72A1D6E6-EA1E-4324-92B0-06A1E2103D30Q59127565-A365AA7E-7807-4086-9007-FDE7FC93B894Q59134758-E7BC04BD-CBC4-457D-BE8D-B43B8AE1F0BA
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
RNA editing with CRISPR-Cas13.
@en
RNA editing with CRISPR-Cas13.
@nl
type
label
RNA editing with CRISPR-Cas13.
@en
RNA editing with CRISPR-Cas13.
@nl
prefLabel
RNA editing with CRISPR-Cas13.
@en
RNA editing with CRISPR-Cas13.
@nl
P2860
P50
P356
P1433
P1476
RNA editing with CRISPR-Cas13
@en
P2093
Julia Joung
P2860
P304
P356
10.1126/SCIENCE.AAQ0180
P407
P577
2017-10-25T00:00:00Z